CAS: 1621999-82-3

CC-90003 is a clinical-stage, small molecule inhibitor of the extracellular signal regulated kinase (ERK) pathway. CC-90003 binds to activated growth factor receptors and inhibits the phosphorylation of ERKs. CC-90003 has been shown to be effective in treating metastatic colorectal cancer. The drug is being developed as a processable, clinical use drug that can be administered by intravenous injection.

CC-90003

N-(2-((2-((2-Methoxy-5-methylpyridin-4-yl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)-5-methylph

CC-90003 is a selective inhibitor of ERK 1/2. It has antitumor activity.